Tenaya Therapeutics, Inc.
(NASDAQ: TNYA)
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. Its programs include TN-201, TN-401, and TN-301. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Newell Olson in 2016 and is headquartered in South San Francisco, CA.
1.385
+0.005
(+0.36%)
Range
1.360 - 1.410
(3.68%)
Open
1.400
Previous Close
1.380
Bid Price
7.320
Bid Volume
14
Ask Price
7.370
Ask Volume
13
Volume
829,845
Value
-
Remark
Delayed prices. Updated at 06 Dec 2025 02:07.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
